Long-term results and predictors of failure after mechanochemical endovenous ablation in the treatment of primary great saphenous vein incompetence

Phlebology. 2024 Feb;39(1):9-19. doi: 10.1177/02683555231202181. Epub 2023 Sep 15.

Abstract

Background: Mechanochemical endovenous ablation (MOCA) was introduced to treat superficial venous insufficiency of the lower leg with less pain and haematoma. Long-term outcome is still lacking. The purpose was to report long-term outcome and to analyse possible predictors for failure.

Methods: The study was a retrospective pooled analysis of two prospective cohorts previously reported, but with prolonged long-term outcome up to 5-years follow-up.

Results: 163 treated legs were analysed. Mean follow-up was 5.4±0.6 years, in which 33 total failures occurred. Four procedures were partially successful. VCSS improved significantly and remained stable after 1 and 2-years, but significantly rose again after 5-years. AVVQ dropped significantly, but increased after 1 year to 4.3 and 6.1 at 5-years follow-up.

Conclusion: MOCA was effective with minimal pain perioperative. However, anatomical success deteriorated after 1-year and showed even less results after 5-years, mainly due to partly recanalization, while clinical results were less affected. There were no clear clinical predictors for failure.

Keywords: great saphenous vein; lower leg; mechanochemical endovenous ablation; superficial venous insufficiency.

MeSH terms

  • Endovascular Procedures* / methods
  • Humans
  • Pain
  • Prospective Studies
  • Retrospective Studies
  • Saphenous Vein / surgery
  • Treatment Outcome
  • Varicose Veins* / surgery
  • Venous Insufficiency* / surgery